Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 25 Breast Neoplasms 14 Neoplasms 12 Myelodysplastic Syndromes 12 Prostatic Neoplasms 10 Multiple Myeloma 8 Lung Neoplasms 7 Stomach Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 5 Leukemia, Myelomonocytic, Chronic 5 Recurrence 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumor 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor 3 Small Cell Lung Carcinoma 3 Pain 3 Mucositis 3 Lymphoma, T-Cell, Peripheral 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomatitis 2 Skin Neoplasms 2

Interventions

Metformin 18 Inositol 5 Exercise 4 Pioglitazone 3 Insulin 3 Ethinyl Estradiol 3 drospirenone and ethinyl estradiol combination 2 Surveys and Questionnaires 2 Cyproterone Acetate 2 Acupuncture Therapy 2 ziprasidone 1 salicylsalicylic acid 1 maltodextrin 1 licogliflozin 1 exendin (9-39) 1 drospirenone 1 cinnulin PF 1 Zoledronic Acid 1 Waist-Hip Ratio 1 Waist Circumference 1 Vitamin D 1 Time 1 Thioctic Acid 1 Tablets 1 Sulfasalazine 1 Sugars 1 Sodium-Glucose Transporter 2 Inhibitors 1 Sodium Salicylate 1 Saline Solution 1 Resistance Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Insulin Resistance × Injections × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡